These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36785966)

  • 1. [Morphological precursors of high-grade serous ovarian cancer].
    Novikov FV; Efremov GD
    Arkh Patol; 2023; 85(1):74-78. PubMed ID: 36785966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma].
    Zhao RJ; Wang YY; Li Z; Wu KY; Kong LF; Zheng WX
    Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):542-547. PubMed ID: 28810294
    [No Abstract]   [Full Text] [Related]  

  • 3. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
    Wen J; Shi JL; Shen DH; Chen YX; Song QJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory cell outgrowths, p53 signatures, and serous tubal intraepithelial carcinoma in the fallopian tubes of patients with sporadic pelvic serous carcinoma.
    Mittal N; Srinivasan R; Gupta N; Rajwanshi A; Nijhawan R; Gautam U; Sood S; Dhaliwal L
    Indian J Pathol Microbiol; 2016; 59(4):481-488. PubMed ID: 27721278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expansion of secretory cells in the fallopian tubal epithelium in the early stages of the pathogenesis of ovarian serous carcinomas].
    Asaturova AV; Ezhova LS; Faizullina NM; Adamyan LV; Khabas GN; Sannikova MV
    Arkh Patol; 2017; 79(3):10-18. PubMed ID: 28631711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
    Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
    Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
    Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
    Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 9. Serous tubal in situ carcinoma (STIC) in primary peritoneal serous carcinomas.
    Horn LC; Kafkova S; Leonhardt K; Kellner C; Einenkel J
    Int J Gynecol Pathol; 2013 Jul; 32(4):339-44. PubMed ID: 23722505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.
    Vang R; Shih IeM; Kurman RJ
    Histopathology; 2013 Jan; 62(1):44-58. PubMed ID: 23240669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
    Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
    BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Fallopian tube odyssey: from the ovary to the tube. About high-grade serous ovarian carcinoma].
    Chêne G; Dauplat J; Radosevic-Robin N; Cayre A; Penault-Llorca F
    Bull Cancer; 2013; 100(7-8):757-64. PubMed ID: 23831931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serous tubal intraepithelial carcinoma, chronic fallopian tube injury, and serous carcinoma development.
    Malmberg K; Klynning C; Flöter-Rådestad A; Carlson JW
    Virchows Arch; 2016 Jun; 468(6):707-13. PubMed ID: 27003156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction pathway activity in high-grade serous carcinoma, its precursors and Fallopian tube epithelium.
    van der Ploeg P; Uittenboogaard A; Bosch SL; van Diest PJ; Wesseling-Rozendaal YJW; van de Stolpe A; Lambrechts S; Bekkers RLM; Piek JMJ
    Gynecol Oncol; 2022 Apr; 165(1):114-120. PubMed ID: 35123772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of dysplastic changes in the uterine tubal epithelium in the histogenesis of ovarian cancer].
    Danilova NV; Andreeeva IuIu; Korolev AV; Vinogradov II; Zavalishina LE; Frank GA
    Arkh Patol; 2014; 76(4):9-14. PubMed ID: 25306618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift.
    Reade CJ; McVey RM; Tone AA; Finlayson SJ; McAlpine JN; Fung-Kee-Fung M; Ferguson SE
    J Obstet Gynaecol Can; 2014 Feb; 36(2):133-140. PubMed ID: 24518912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of γ-H2AX and p53 nuclear expression levels in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomies in BRCA1 and BRCA2 mutation carriers.
    Staff S; Tolonen T; Laasanen SL; Mecklin JP; Isola J; Mäenpää J
    Int J Gynecol Pathol; 2014 May; 33(3):309-16. PubMed ID: 24681744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of ovarian high-grade serous carcinoma from time effects of ovulation inhibition and progesterone clearance of p53-defective lesions.
    Wu NY; Fang C; Huang HS; Wang J; Chu TY
    Mod Pathol; 2020 Jan; 33(1):29-37. PubMed ID: 31558785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of serous tubal intraepithelial carcinoma (STIC) by algorithm classification in serous ovarian tumor associated with PAX8 expression in tubal epithelia: a study of single institution in Japan.
    Munakata S; Yamamoto T
    Int J Gynecol Pathol; 2015 Jan; 34(1):9-18. PubMed ID: 25473747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of serous tubal intraepithelial carcinoma with gynecologic pathologies and its role in pelvic serous cancer.
    Koç N; Ayas S; Uygur L
    Gynecol Oncol; 2014 Sep; 134(3):486-91. PubMed ID: 25038287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.